Cargando…
An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages
Leishmaniasis is a tropical disease threatening 350 million people from endemic regions. The available drugs for treatment are inadequate, with limitations such as serious side effects, parasite resistance or high cost. Driven by this need for new drugs, we developed a high-content, high-throughput...
Autores principales: | Siqueira-Neto, Jair L., Moon, Seunghyun, Jang, Jiyeon, Yang, Gyongseon, Lee, Changbok, Moon, Hong Kee, Chatelain, Eric, Genovesio, Auguste, Cechetto, Jonathan, Freitas-Junior, Lucio H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373640/ https://www.ncbi.nlm.nih.gov/pubmed/22720099 http://dx.doi.org/10.1371/journal.pntd.0001671 |
Ejemplares similares
-
Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds
por: Siqueira-Neto, Jair L., et al.
Publicado: (2010) -
Arginase Is Essential for Survival of Leishmania donovani Promastigotes but Not Intracellular Amastigotes
por: Boitz, Jan M., et al.
Publicado: (2016) -
Leishmania Donovani. Hamster macrophage interactions in vitro: cell entry, intracellular survival, and multiplication of amastigotes
por: Chang, K-P, et al.
Publicado: (1978) -
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
por: Cechetto, Jonathan, et al.
Publicado: (2011) -
Leishmania donovani development in Phlebotomus argentipes: comparison of promastigote- and amastigote-initiated infections
por: SADLOVA, JOVANA, et al.
Publicado: (2017)